Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: A substudy of the Multicenter AIDS Cohort Study

AIDS Research and Therapy

Volumn 6, Issue , 2009, Pages

  Brown, Todd T ^a   Xu, Xiaoqiang ^a   John, Majnu ^b   Singh, Jaya ^c   Kingsley, Lawrence A ^d   Palella, Frank J ^e   Witt, Mallory D ^f   Margolick, Joseph B ^a   Dobs, Adrian S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c Saint Clare's Hospital   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SUBCUTANEOUS FAT; THIGH; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 66749143540     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-6-8     Document Type: Article

References (26)

1. Grinspoon S Carr A Cardiovascular risk and body-fat abnormalities in HIV-infected adults N Engl J Med 2005, 352:48-62. 10.1056/NEJMra041811 15635112
2. Lichtenstein KA Redefining lipodystrophy syndrome: Risks and impact on clinical decision making J Acquir Immune Defic Syndr 2005, 39:395-400. 10.1097/01.qai.0000167478.28051.3a 16010159
3. Hadigan C Meigs JB Corcoran C Rietschel P Piecuch S Basgoz N Davis B Sax P Stanley T Wilson PW et al Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy Clin Infect Dis 2001, 32:130-139. 10.1086/ 317541 11118392
4. Saves M Raffi F Capeau J Rozenbaum W Ragnaud JM Perronne C Basdevant A Leport C Chene G Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy Clin Infect Dis 2002, 34:1396-1405. 10.1086/339866 11981737
5. Bacchetti P Gripshover B Grunfeld C Heymsfield S McCreath H Osmond D Saag M Scherzer R Shlipak M Tien P Fat distribution in men with HIV infection J Acquir Immune Defic Syndr 2005, 40:121-131. 10.1097/ 01.qai.0000182230.47819.aa 16186728
6. Fat distribution in women with HIV infection J Acquir Immune Defic Syndr 2006, 42:562-571. 10.1097/01.qai.0000229996.75116.da 16837863
7. Dolan SE Hadigan C Killilea KM Sullivan MP Hemphill L Lees RS Schoenfeld D Grinspoon S Increased Cardiovascular Disease Risk Indices in HIV-Infected Women J Acquir Immune Defic Syndr 2005, 39:44-54. 10.1097/ 01.qai.0000159323.59250.83 15851913
8. Brown TT Chu H Wang Z Palella FJ Kingsley L Witt MD Dobs AS Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy AIDS 2007, 21:1731-1738. 10.1097/ QAD.0b013e328270356a 17690571
9. Palella FJ Jr Cole SR Chmiel JS Riddler SA Visscher B Dobs A Williams C Anthropometrics and examiner-reported body habitus abnormalities in the multicenter AIDS cohort study Clin Infect Dis 2004, 38:903-907. 10.1086/ 381684 14999638
10. Dybul M Fauci AS Bartlett JG Kaplan JE Pau AK Guidelines for using antiretroviral agents among HIV-infected adults and adolescents Ann Intern Med 2002, 137:381-433. 12617573
11. Brown T Wang Z Chu H Palella FJ Kingsley L Witt MD Dobs AS Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men J Acquir Immune Defic Syndr 2006, 43:356-362. 10.1097/01.qai.0000243052.73321.8e 16980910
12. National Health and Nutrition Examination Survey III: Body Measurements (Anthropometry) Westat, Inc. 1988. http://www.cdc.gov/nchs/data/nhanes/ nhanes3/cdrom/NCHS/MANUALS/ANTHRO.PDF
13. Littell RC Milliken GA Stroup WW Wolfinger R SAS System for Mixed Models Cary, NC, USA 1996.
14. Carr A Emery S Law M Puls R Lundgren JD Powderly WG An objective case definition of lipodystrophy in HIV-infected adults: A case-control study Lancet 2003, 361:726-735. 10.1016/S0140-6736(03)12656-6 12620736
15. Saint-Marc T Partisani M Poizot-Martin I Rouviere O Bruno F Avellaneda R Lang JM Gastaut JA Touraine JL Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study AIDS 2000, 14:37-49. 10.1097/00002030-200001070-00005 10714566
16. Joy T Keogh HM Hadigan C Dolan SE Fitch K Liebau J Johnsen S Lo J Grinspoon SK Relation of body composition to body mass index in HIV-infected patients with metabolic abnormalities J Acquir Immune Defic Syndr 2008, 47:174-184. 10.1097/QAI.0b013e31815b0792 17971710
17. Kosmiski LA Kuritzkes DR Sharp TA Hamilton JT Lichtenstein KA Mosca CL Grunwald GK Eckel RH Hill JO Total energy expenditure and carbohydrate oxidation are increased in the human immunodeficiency virus lipodystrophy syndrome Metabolism 2003, 52:620-625. 10.1053/ meta.2003.50103 12759894
18. Shevitz AH Knox TA Spiegelman D Roubenoff R Gorbach SL Skolnik PR Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy AIDS 1999, 13:1351-1357. 10.1097/00002030-199907300-00012 10449288
19. Delpierre C Bonnet E Marion-Latard F Aquilina C Obadia M Marchou B Massip P Perret B Bernard J Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls J Clin Densitom 2007, 10:376-380. 10.1016/j.jocd.2007.07.006 17888698
20. Grunfeld C Rimland D Gibert CL Powderly WG Sidney S Shlipak MG Bacchetti P Scherzer R Haffner S Heymsfield SB Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study J Acquir Immune Defic Syndr 2007, 46:283-290. 10.1097/QAI.0b013e31814b94e2 18167644
21. Wohl D Scherzer R Heymsfield S Simberkoff M Sidney S Bacchetti P Grunfeld C The Associations of Regional Adipose Tissue With Lipid and Lipoprotein Levels in HIV-Infected Men J Acquir Immune Defic Syndr 2008, 48:44-52. 10.1097/QAI.0b013e31816d9ba1 18360291
22. Carr DB Utzschneider KM Hull RL Kodama K Retzlaff BM Brunzell JD Shofer JB Fish BE Knopp RH Kahn SE Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome Diabetes 2004, 53:2087-2094. 10.2337/ diabetes.53.8.2087 15277390
23. Nieves DJ Cnop M Retzlaff B Walden CE Brunzell JD Knopp RH Kahn SE The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat Diabetes 2003, 52:172-179. 10.2337/diabetes.52.1.172 12502509
24. Bray GA Jablonski KA Fujimoto WY Barrett-Connor E Haffner S Hanson RL Hill JO Hubbard V Kriska A Stamm E et al Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program Am J Clin Nutr 2008, 87:1212-1218. 2517222 18469241
25. Mahabadi AA Massaro JM Rosito GA Levy D Murabito JM Wolf PA O'Donnell CJ Fox CS Hoffmann U Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: The Framingham Heart Study Eur Heart J 2009, 30:850-856. 10.1093/eurheartj/ ehn573 19136488
26. Tien PC, Grunfeld C: What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection. Curr Opin Infect Dis 2004, 17:27-32. 10.1097/00001432-200402000-00005 15090886